Featured Article
Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before interest and taxes rose 22 % to $674 million over the same period last year. A review of Boston Scientific’s 24 April earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Pricing was not mentioned in their earnings call. Margins were briefly mentioned by…
Read MoreIn This Issue
Trade Shows, Booth Duty, Event Calendar. Why do we do this? Where is the bang for the buck? If we are to…
Read More According to Frederick Webster of Tuck School of Business, marketing is charged with three distinct areas of responsibility: (1) communicate to the…
Read More When firms want to escape hand-to-mouth business and enter a somewhat predictable high-growth market, business leaders have to change from opportunism and…
Read More When company names appear in my column, I have noticed a trend of corporate officers contacting me to ask how I learned…
Read More